GABAA受体在神经元功能和疾病中的蛋白平衡调节。

IF 6.9 2区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL
Xi Chen , Ya-Juan Wang , Ting-Wei Mu
{"title":"GABAA受体在神经元功能和疾病中的蛋白平衡调节。","authors":"Xi Chen ,&nbsp;Ya-Juan Wang ,&nbsp;Ting-Wei Mu","doi":"10.1016/j.biopha.2025.117992","DOIUrl":null,"url":null,"abstract":"<div><div>The γ-aminobutyric acid type A receptors (GABA<sub>A</sub>Rs) are ligand-gated anion channels that mediate fast inhibitory neurotransmission in the mammalian central nervous system. GABA<sub>A</sub>Rs form heteropentameric assemblies comprising two α1, two β2, and one γ2 subunits as the most common subtype in mammalian brains. Proteostasis regulation of GABA<sub>A</sub>Rs involves subunit folding within the endoplasmic reticulum, assembling into heteropentamers, receptor trafficking to the cell surface, and degradation of terminally misfolded subunits. As GABA<sub>A</sub>Rs are surface proteins, their trafficking to the plasma membrane is critical for proper receptor function. Thus, variants in the genes encoding GABA<sub>A</sub>Rs that disrupt proteostasis result in various neurodevelopmental disorders, ranging from intellectual disability to idiopathic generalized epilepsy. This review summarizes recent progress about how the proteostasis network regulates protein folding, assembly, degradation, trafficking, and synaptic clustering of GABA<sub>A</sub>Rs. Additionally, emerging pharmacological approaches that restore proteostasis of pathogenic GABA<sub>A</sub>R variants are presented, providing a promising strategy to treat related neurological diseases.</div></div>","PeriodicalId":8966,"journal":{"name":"Biomedicine & Pharmacotherapy","volume":"186 ","pages":"Article 117992"},"PeriodicalIF":6.9000,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Proteostasis regulation of GABAA receptors in neuronal function and disease\",\"authors\":\"Xi Chen ,&nbsp;Ya-Juan Wang ,&nbsp;Ting-Wei Mu\",\"doi\":\"10.1016/j.biopha.2025.117992\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>The γ-aminobutyric acid type A receptors (GABA<sub>A</sub>Rs) are ligand-gated anion channels that mediate fast inhibitory neurotransmission in the mammalian central nervous system. GABA<sub>A</sub>Rs form heteropentameric assemblies comprising two α1, two β2, and one γ2 subunits as the most common subtype in mammalian brains. Proteostasis regulation of GABA<sub>A</sub>Rs involves subunit folding within the endoplasmic reticulum, assembling into heteropentamers, receptor trafficking to the cell surface, and degradation of terminally misfolded subunits. As GABA<sub>A</sub>Rs are surface proteins, their trafficking to the plasma membrane is critical for proper receptor function. Thus, variants in the genes encoding GABA<sub>A</sub>Rs that disrupt proteostasis result in various neurodevelopmental disorders, ranging from intellectual disability to idiopathic generalized epilepsy. This review summarizes recent progress about how the proteostasis network regulates protein folding, assembly, degradation, trafficking, and synaptic clustering of GABA<sub>A</sub>Rs. Additionally, emerging pharmacological approaches that restore proteostasis of pathogenic GABA<sub>A</sub>R variants are presented, providing a promising strategy to treat related neurological diseases.</div></div>\",\"PeriodicalId\":8966,\"journal\":{\"name\":\"Biomedicine & Pharmacotherapy\",\"volume\":\"186 \",\"pages\":\"Article 117992\"},\"PeriodicalIF\":6.9000,\"publicationDate\":\"2025-03-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biomedicine & Pharmacotherapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0753332225001866\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedicine & Pharmacotherapy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0753332225001866","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

γ-氨基丁酸A型受体(GABAARs)是哺乳动物中枢神经系统中介导快速抑制性神经传递的配体门控阴离子通道。GABAARs形成异戊二聚体,包括两个α1、两个β2和一个γ2亚基,是哺乳动物大脑中最常见的亚型。GABAARs的蛋白质稳态调节涉及内质网内亚基折叠、组装成异聚体、受体运输到细胞表面以及最终错误折叠亚基的降解。由于GABAARs是表面蛋白,它们的转运到质膜对受体的正常功能至关重要。因此,编码GABAARs的基因变异破坏蛋白质平衡,导致各种神经发育障碍,从智力残疾到特发性全身性癫痫。本文综述了蛋白质静止网络如何调控GABAARs的蛋白质折叠、组装、降解、转运和突触聚集的最新进展。此外,新兴的药理学方法可以恢复致病性GABAAR变异的蛋白质平衡,为治疗相关神经系统疾病提供了一个有希望的策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Proteostasis regulation of GABAA receptors in neuronal function and disease
The γ-aminobutyric acid type A receptors (GABAARs) are ligand-gated anion channels that mediate fast inhibitory neurotransmission in the mammalian central nervous system. GABAARs form heteropentameric assemblies comprising two α1, two β2, and one γ2 subunits as the most common subtype in mammalian brains. Proteostasis regulation of GABAARs involves subunit folding within the endoplasmic reticulum, assembling into heteropentamers, receptor trafficking to the cell surface, and degradation of terminally misfolded subunits. As GABAARs are surface proteins, their trafficking to the plasma membrane is critical for proper receptor function. Thus, variants in the genes encoding GABAARs that disrupt proteostasis result in various neurodevelopmental disorders, ranging from intellectual disability to idiopathic generalized epilepsy. This review summarizes recent progress about how the proteostasis network regulates protein folding, assembly, degradation, trafficking, and synaptic clustering of GABAARs. Additionally, emerging pharmacological approaches that restore proteostasis of pathogenic GABAAR variants are presented, providing a promising strategy to treat related neurological diseases.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
11.90
自引率
2.70%
发文量
1621
审稿时长
48 days
期刊介绍: Biomedicine & Pharmacotherapy stands as a multidisciplinary journal, presenting a spectrum of original research reports, reviews, and communications in the realms of clinical and basic medicine, as well as pharmacology. The journal spans various fields, including Cancer, Nutriceutics, Neurodegenerative, Cardiac, and Infectious Diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信